William Blair & Company’s Medpace MEDP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.24M | Buy |
7,999
+481
| +6% | +$222K | 0.01% | 560 |
|
|
2026
Q1 | $3.61M | Sell |
7,518
-482
| -6% | -$247K | 0.01% | 577 |
|
|
2025
Q4 | $4.49M | Buy |
8,000
+23
| +0.3% | +$13.1K | 0.01% | 546 |
|
|
2025
Q3 | $4.1M | Sell |
7,977
-292
| -4% | -$127K | 0.01% | 570 |
|
|
2025
Q2 | $2.6M | Sell |
8,269
-25,146
| -75% | -$7.55M | 0.01% | 655 |
|
|
2025
Q1 | $10.2M | Sell |
33,415
-730
| -2% | -$246K | 0.03% | 327 |
|
|
2024
Q4 | $11.3M | Sell |
34,145
-25,173
| -42% | -$8.54M | 0.03% | 318 |
|
|
2024
Q3 | $19.8M | Buy |
59,318
+33,463
| +129% | +$12.7M | 0.06% | 234 |
|
|
2024
Q2 | $10.6M | Buy |
25,855
+1,004
| +4% | +$398K | 0.03% | 316 |
|
|
2024
Q1 | $10M | Buy |
24,851
+7,521
| +43% | +$2.64M | 0.03% | 330 |
|
|
2023
Q4 | $5.31M | Buy |
17,330
+4,656
| +37% | +$1.26M | 0.02% | 448 |
|
|
2023
Q3 | $3.07M | Buy |
12,674
+620
| +5% | +$159K | 0.01% | 553 |
|
|
2023
Q2 | $2.9M | Sell |
12,054
-130
| -1% | -$27K | 0.01% | 577 |
|
|
2023
Q1 | $2.29M | Buy |
12,184
+650
| +6% | +$134K | 0.01% | 621 |
|
|
2022
Q4 | $2.45M | Sell |
11,534
-746
| -6% | -$149K | 0.01% | 580 |
|
|
2022
Q3 | $1.93M | Sell |
12,280
-5,659
| -32% | -$903K | 0.01% | 629 |
|
|
2022
Q2 | $2.69M | Buy |
17,939
+201
| +1% | +$29.1K | 0.01% | 564 |
|
|
2022
Q1 | $2.9M | Sell |
17,738
-154
| -0.9% | -$25.4K | 0.01% | 600 |
|
|
2021
Q4 | $3.89M | Sell |
17,892
-131
| -0.7% | -$27.4K | 0.01% | 544 |
|
|
2021
Q3 | $3.41M | Sell |
18,023
-15
| -0.1% | -$2.74K | 0.01% | 552 |
|
|
2021
Q2 | $3.19M | Sell |
18,038
-156
| -0.9% | -$26.9K | 0.01% | 576 |
|
|
2021
Q1 | $2.98M | Sell |
18,194
-7,939
| -30% | -$1.21M | 0.01% | 574 |
|
|
2020
Q4 | $3.64M | Sell |
26,133
-797
| -3% | -$100K | 0.01% | 504 |
|
|
2020
Q3 | $3.01M | Buy |
26,930
+7,616
| +39% | +$881K | 0.01% | 497 |
|
|
2020
Q2 | $1.8M | Buy |
19,314
+6,147
| +47% | +$523K | 0.01% | 580 |
|
|
2020
Q1 | $966K | Sell |
13,167
-1,145
| -8% | -$99.4K | 0.01% | 676 |
|
|
2019
Q4 | $1.2M | Buy |
14,312
+802
| +6% | +$62.1K | 0.01% | 729 |
|
|
2019
Q3 | $1.14M | Buy |
13,510
+3,220
| +31% | +$243K | 0.01% | 711 |
|
|
2019
Q2 | $673K | Sell |
10,290
-4,274
| -29% | -$246K | ﹤0.01% | 883 |
|
|
2019
Q1 | $859K | Buy |
14,564
+10,361
| +247% | +$619K | 0.01% | 783 |
|
|
2018
Q4 | $222K | Buy |
+4,203
| New | +$231K | ﹤0.01% | 1197 |
|
Other funds holding MEDP
WA
William Blair & Company's MEDP Position: Q2 2026 in Review
William Blair & Company increased its Medpace (MEDP) stake by 6.4% in Q2 2026, buying an estimated $222K and bringing the position to 7,999 shares worth $4.24M. The position accounts for 0.01% of the portfolio, ranked #560.
William Blair & Company first reported a position in MEDP in Q4 2018 and has held it in 31 quarters since. The position peaked at $19.8M in Q3 2024. 697 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.
- William Blair & Company held 7,999 shares of Medpace worth $4.24M as of Q2 2026.
- William Blair & Company bought 481 Medpace shares in Q2 2026, an estimated $222K.
- Medpace made up 0.01% of William Blair & Company's portfolio in Q2 2026, its #560 holding.
- William Blair & Company first reported a position in Medpace in Q4 2018 and has held it in 31 quarters since.
- William Blair & Company's Medpace position peaked at $19.8M in Q3 2024.
- 697 funds tracked by Wall St. Rank held Medpace as of Q2 2026.
Based on William Blair & Company's 13F filing for Q2 2026, filed 11 Aug 2026.